Martin Fahlén

1.5k total citations
34 papers, 1.1k citations indexed

About

Martin Fahlén is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Martin Fahlén has authored 34 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Cardiology and Cardiovascular Medicine and 7 papers in Molecular Biology. Recurrent topics in Martin Fahlén's work include Diabetes Management and Research (9 papers), Diabetes Treatment and Management (7 papers) and Atrial Fibrillation Management and Outcomes (5 papers). Martin Fahlén is often cited by papers focused on Diabetes Management and Research (9 papers), Diabetes Treatment and Management (7 papers) and Atrial Fibrillation Management and Outcomes (5 papers). Martin Fahlén collaborates with scholars based in Sweden, United States and Italy. Martin Fahlén's co-authors include Anders Odén, Björn Eliasson, Marcus Lind, Per Björntorp, Robert G. Hart, Anders Gustafson, Jan Holm, T. Scherstén, Gunnar Grimby and Per A.F.H. Renström and has published in prestigious journals such as PLoS ONE, Stroke and Diabetologia.

In The Last Decade

Martin Fahlén

33 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin Fahlén Sweden 17 360 334 245 194 164 34 1.1k
Bruce R. Zimmerman United States 14 470 1.3× 164 0.5× 219 0.9× 77 0.4× 342 2.1× 27 1.1k
Daniel Bottino Brazil 17 131 0.4× 199 0.6× 232 0.9× 67 0.3× 177 1.1× 55 811
Nigel Wheeldon United Kingdom 18 370 1.0× 1.1k 3.2× 106 0.4× 45 0.2× 216 1.3× 40 1.6k
K. G. Stanton Australia 14 361 1.0× 307 0.9× 267 1.1× 59 0.3× 150 0.9× 24 942
A Amery Belgium 21 314 0.9× 972 2.9× 132 0.5× 36 0.2× 295 1.8× 112 1.6k
K. H. Tønnesen Denmark 18 119 0.3× 225 0.7× 111 0.5× 30 0.2× 606 3.7× 64 1.1k
Giovanni B. Ambrosio Italy 20 225 0.6× 762 2.3× 156 0.6× 66 0.3× 221 1.3× 36 1.3k
Sergio Bevilacqua Italy 17 435 1.2× 520 1.6× 611 2.5× 215 1.1× 519 3.2× 45 1.7k
Robert E. Shangraw United States 18 216 0.6× 84 0.3× 356 1.5× 208 1.1× 165 1.0× 40 1.1k
JR Attali France 21 349 1.0× 447 1.3× 199 0.8× 29 0.1× 290 1.8× 48 1.2k

Countries citing papers authored by Martin Fahlén

Since Specialization
Citations

This map shows the geographic impact of Martin Fahlén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Fahlén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Fahlén more than expected).

Fields of papers citing papers by Martin Fahlén

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Fahlén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Fahlén. The network helps show where Martin Fahlén may publish in the future.

Co-authorship network of co-authors of Martin Fahlén

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Fahlén. A scholar is included among the top collaborators of Martin Fahlén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Fahlén. Martin Fahlén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lesén, Eva, Ingela Björholt, Åse Björstad, Martin Fahlén, & Anders Odén. (2014). Impact of short periods with worsened or improved INR control on life expectancy and QALYs in patients with atrial fibrillation. Thrombosis Research. 133(6). 1061–1067. 4 indexed citations
2.
Lesén, Eva, Ingela Björholt, Åse Björstad, Martin Fahlén, & Anders Odén. (2013). Impact of Short Periods with Improved or Worsened INR Control on Life Expectancy and QALYs in Patients with Atrial Fibrillation. Value in Health. 16(7). A328–A328. 1 indexed citations
3.
Lind, Marcus, Martin Fahlén, Mikhail Kosiborod, Björn Eliasson, & Anders Odén. (2011). Variability of INR and its relationship with mortality, stroke, bleeding and hospitalisations in patients with atrial fibrillation. Thrombosis Research. 129(1). 32–35. 58 indexed citations
4.
5.
Attvall, Stig, et al.. (2011). Effect on Glycemic Control by Short- and Long-Term Use of Continuous Glucose Monitoring in Clinical Practice. Journal of Diabetes Science and Technology. 5(6). 1472–1479. 13 indexed citations
6.
Lind, Marcus, Anders Odén, Martin Fahlén, & Björn Eliasson. (2010). The shape of the metabolic memory of HbA1c: re-analysing the DCCT with respect to time-dependent effects. Diabetologia. 53(6). 1093–1098. 72 indexed citations
7.
Lind, Marcus, Anders Odén, Martin Fahlén, & Björn Eliasson. (2009). The True Value of HbA1c as a Predictor of Diabetic Complications: Simulations of HbA1c Variables. PLoS ONE. 4(2). e4412–e4412. 69 indexed citations
8.
Lind, Marcus, Martin Fahlén, Michael Happich, Anders Odén, & Björn Eliasson. (2009). The Effect of Insulin Lispro on Glycemic Control in a Large Patient Cohort. Diabetes Technology & Therapeutics. 11(1). 51–56. 9 indexed citations
9.
Fahlén, Martin, et al.. (2007). A method to predict the metabolic effects of changes in insulin treatment in subgroups of a large population based patient cohort. European Journal of Epidemiology. 22(3). 151–157. 12 indexed citations
10.
Fahlén, Martin, Björn Eliasson, & Anders Odén. (2005). Optimization of basal insulin delivery in Type 1 diabetes: a retrospective study on the use of continuous subcutaneous insulin infusion and insulin glargine. Diabetic Medicine. 22(4). 382–386. 24 indexed citations
11.
Odén, Anders, Martin Fahlén, & Robert G. Hart. (2004). Optimal INR for prevention of stroke and death in atrial fibrillation: a critical appraisal. Thrombosis Research. 117(5). 493–499. 111 indexed citations
12.
Odén, Anders & Martin Fahlén. (2003). Oral anticoagulation and risk of death: a medical record linkage study. ACC Current Journal Review. 12(2). 18–19. 7 indexed citations
13.
Lapidus, Leif, et al.. (2002). Home Treatment of Deep Vein Thrombosis. Pathophysiology of Haemostasis and Thrombosis. 32(2). 59–66. 21 indexed citations
14.
Hårdemark, Hans‐Göran, A. Lindgren, Bo Norrving, et al.. (2001). Management and Prognostic Features of Intracerebral Hemorrhage During Anticoagulant Therapy: A Swedish Multicenter Study. Stroke. 32(11). 2567–2574. 159 indexed citations
15.
Fahlén, Martin, et al.. (1983). Home Monitoring of Blood Glucose and Insulin Therapy without a Photometer. Acta Medica Scandinavica. 213(S671). 37–43.
16.
Fahlén, Martin, et al.. (1974). Enzyme Activities in Muscle and Liver After Destruction of the Ventromedial Hypothalamic Area and Administration of Insulin. Hormone and Metabolic Research. 6(3). 222–226. 5 indexed citations
17.
Bergman, Halvar, et al.. (1973). Enzymatic and Circulatory Adjustments to Physical Training in Middle‐Aged Men*. European Journal of Clinical Investigation. 3(5). 414–418. 16 indexed citations
18.
Gustafson, Anders, Per Björntorp, & Martin Fahlén. (1971). METFORMIN ADMINISTRATION IN HYPERLIPIDEMIC STATES. Acta Medica Scandinavica. 190(1-6). 491–494. 20 indexed citations
19.
Fahlén, Martin, Anders Odén, Per Björntorp, & Gösta Tibblin. (1971). Seasonal Influence on Insulin Secretion in Man. Clinical Science. 41(5). 453–458. 38 indexed citations
20.
Björntorp, Per, et al.. (1970). Determination of Succinic Oxidase Activity in Human Skeletal Muscle. Scandinavian Journal of Clinical and Laboratory Investigation. 26(2). 145–150. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bruce R. Zimmerman Breakdown of academic impact, for papers by Daniel Bottino Breakdown of academic impact, for papers by Nigel Wheeldon Breakdown of academic impact, for papers by K. G. Stanton Breakdown of academic impact, for papers by A Amery Breakdown of academic impact, for papers by K. H. Tønnesen Breakdown of academic impact, for papers by Giovanni B. Ambrosio Breakdown of academic impact, for papers by Sergio Bevilacqua Breakdown of academic impact, for papers by Robert E. Shangraw Breakdown of academic impact, for papers by JR Attali
Rankless by CCL
2026